Of 5,634 tests carried out over the past day, 30.3% were positive, resulting in 1,705 confirmed new cases of infection. The 14-day cumulative incidence rate per 100,000 population rose from 948 Monday to 976 Tuesday.
📈 Pēdējo 24h laikā:
— SPKC.gov.lv (@SPKCentrs) August 2, 2022
▫️veikti 5634 Covid-19 izmeklējumi;
▫️reģistrēti 1705 jauni inficēšanās gadījumi, no tiem 736 nevakcinēti vai vakcinācijas kursu nepabeiguši, 969 vakcinēti;
Since the beginning of the pandemic, 866,034 Covid-19 cases have now been recorded among Latvia's 1.9 million population.
The total death toll since the beginning of the pandemic stands at 5,899. One of the three most recent fatalities was aged 40-49 years and the two others were aged 80 and over.
Monday hospital data from the National Health Service (NVD) show 180 patients being treated in hospitals, two of whom are displaying serious symptoms.
🏥 Aktuālā statistika par Covid-19 pacientu ārstēšanu stacionāros. Kopā stacionāros ārstējas 180 Covid-19 pacienti, tajā skaitā 83 ar pamatdiagnozi:
— Nacionālais veselības dienests (@VMNVD) August 1, 2022
🟠 ar vidēji smagu slimības gaitu - 81
🟠 ar smagu slimības gaitu - 2
Jauni gadījumi - 12. Pēdējo 24h laikā izrakstīti - 9. pic.twitter.com/z94wRga6ra
Covid-19 information
A summary in English of the latest Covid-19 situation is available at this special government website.
You can find the latest Covid-19 statistics at this official website.
A hotline – 8989 – allows people to both register for vaccination and receive answers to questions about the process of vaccination will continue to operate. The number for medical emergencies is 113.
There is also a website to register for vaccination, https://manavakcina.lv which includes an English-language version.
If you have been fully vaccinated against Covid-19, or you have fully recovered from a confirmed case of it, you can obtain a digital certificate attesting to your status at the website https://covid19sertifikats.lv.
Latvia is also part of the European Union's wider Covid-19 certification scheme.